Actively Recruiting
Self-Adhering Magnetic Device to Treat Corneal Exposure
Led by University of Illinois at Chicago · Updated on 2024-05-13
25
Participants Needed
1
Research Sites
49 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Paralytic lagophthalmos can be difficult to treat and manage. It has a host of causes and effects, one of which (for the latter) is exposure keratopathy. Untreated, this can lead to corneal ulceration, inflammation, and potentially blindness. Despite a variety of attempts at treating this complex condition, none have satisfactorily reduced complications ranging from ease of use to aesthetics. With improvement in magnetic technology, however, that may change. Barmettler et al (2014) have demonstrated preliminary success of externally affixed magnets in closing both model and patient eyelids. As such, we hypothesize that magnetic devices can be used to treat corneal exposure by controlling eyelid position.
CONDITIONS
Official Title
Self-Adhering Magnetic Device to Treat Corneal Exposure
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Males and females ages 18-80 years old
- Patients with recent corneal abrasion and no signs of infection
- Patients with lagophthalmos
- Normal controls
You will not qualify if you...
- Individuals with adhesive or tape allergies
- Individuals with a history of metal pieces or shavings embedded in the eye
- Individuals with eye infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Illinois - Specialty Care Building
Chicago, Illinois, United States, 60612
Actively Recruiting
Research Team
P
Pete Setabutr, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here